Literature DB >> 15879157

Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis.

Maurizio Carbonari1, Elisabetta Caprini, Tiziana Tedesco, Francesca Mazzetta, Valeria Tocco, Milvia Casato, Giandomenico Russo, Massimo Fiorilli.   

Abstract

Chronic hepatitis C virus infection causes B cell lymphoproliferative disorders that include type II mixed cryoglobulinemia and lymphoma. This virus drives the monoclonal expansion and, occasionally, the malignant transformation of B cells producing a polyreactive natural Ab commonly encoded by the V(H)1-69 variable gene. Owing to their property of producing natural Ab, these cells are reminiscent of murine B-1 and marginal zone B cells. We used anti-Id Abs to track the stages of differentiation and clonal expansion of V(H)1-69(+) cells in patients with type II mixed cryoglobulinemia. By immunophenotyping and cell size analysis, we could define three discrete stages of differentiation of V(H)1-69(+) B cells: naive (small, IgM(high)IgD(high)CD38(+)CD27(-)CD21(high)CD95(-)CD5(-)), "early memory" (medium-sized, IgM(high)IgD(low)CD38(-)CD27(+)CD21(low)CD95(+)CD5(+)), and "late memory" (large-sized, IgM(low)IgD(low-neg)CD38(-)CD27(low)CD21(low-neg)CD5(-)CD95(-)). The B cells expanded in cryoglobulinemia patients have a "memory" phenotype; this fact, together with the evidence for intraclonal variation, suggests that antigenic stimulation by hepatitis C virus causes the unconstrained expansion of activated V(H)1-69(+) B cells. In some cases, these cells replace the entire pool of circulating B cells, although the absolute B cell number remains within normal limits. Absolute monoclonal V(H)1-69(+) B lymphocytosis was seen in three patients with cryoglobulinemia and splenic lymphoma; in two of these patients, expanded cells carried trisomy 3q. The data presented here indicate that the hepatitis C virus-driven clonal expansion of memory B cells producing a V(H)1-69(+) natural Ab escapes control mechanisms and subverts B cell homeostasis. Genetic alterations may provide a further growth advantage leading to an overt lymphoproliferative disorder.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15879157     DOI: 10.4049/jimmunol.174.10.6532

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  Identification of a novel stereotypic IGHV4-59/IGHJ5-encoded B-cell receptor subset expressed by various B-cell lymphomas with high affinity rheumatoid factor activity.

Authors:  Richard J Bende; Jerry Janssen; Thera A M Wormhoudt; Koen Wagner; Jeroen E J Guikema; Carel J M van Noesel
Journal:  Haematologica       Date:  2016-02-08       Impact factor: 9.941

2.  Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.

Authors:  Edgar D Charles; Claudia Brunetti; Svetlana Marukian; Kimberly D Ritola; Andrew H Talal; Kristen Marks; Ira M Jacobson; Charles M Rice; Lynn B Dustin
Journal:  Blood       Date:  2011-03-18       Impact factor: 22.113

3.  A flow cytometry-based strategy to identify and express IgM from VH1-69+ clonal peripheral B cells.

Authors:  Edgar D Charles; Michael I M Orloff; Lynn B Dustin
Journal:  J Immunol Methods       Date:  2010-09-24       Impact factor: 2.303

Review 4.  T-bet-expressing B cells during HIV and HCV infections.

Authors:  James J Knox; David E Kaplan; Michael R Betts
Journal:  Cell Immunol       Date:  2017-07-11       Impact factor: 4.868

5.  Persistence of exhaustion in cured hep C.

Authors:  David E Kaplan
Journal:  Blood       Date:  2017-07-06       Impact factor: 22.113

6.  IL-33 enhances the kinetics and quality of the antibody response to a DNA and protein-based HIV-1 Env vaccine.

Authors:  Sanghita Sarkar; Michael S Piepenbrink; Madhubanti Basu; Juilee Thakar; Michael C Keefer; Ann J Hessell; Nancy L Haigwood; James J Kobie
Journal:  Vaccine       Date:  2019-03-27       Impact factor: 3.641

7.  Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis.

Authors:  Hiroyoshi Doi; Shiroh Tanoue; David E Kaplan
Journal:  Clin Immunol       Date:  2013-12-17       Impact factor: 3.969

Review 8.  Hepatitis C virus-induced cryoglobulinemia.

Authors:  Edgar D Charles; Lynn B Dustin
Journal:  Kidney Int       Date:  2009-07-15       Impact factor: 10.612

9.  Hepatitis C virus infection and locally advanced splenic marginal zone lymphoma.

Authors:  Bartlomiej Szynglarewicz; Rafał Matkowski; Zbigniew Smorag; Jozef Forgacz; Marek Pudelko; Jan Kornafel
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

10.  Successful combination of Rituximab and plasma exchange in the treatment of cryoglobulinemic vasculitis with skin ulcers: a case report.

Authors:  Tiziano Tallarita; Massimiliano Gagliano; Daniela Corona; Giuseppe Giuffrida; Alessia Giaquinta; Domenico Zerbo; Massimiliano Sorbello; Pierfrancesco Veroux; Massimiliano Veroux
Journal:  Cases J       Date:  2009-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.